4Issaragrisil S, Kaufman DW, Anderson T, et al. Incidence and non-drug aefiologies of aplastic anemia in Thailand. Eur J Haematol, 1996, 57 Sup-pl: 31-34.
5Issaragrisil S, Kaufman D, Thongput A, et al. Association of semposifivity for hepatitis viruses and aplastic anemia in Thailand. Hepatology, 1997,25 .. 1255-1257.
6Bozkaya H, Yurdaydin C, Tonmer M, et al. Remission of severe aplastic anemia associated with hepatitis B virus infection after viral clearance: potential role of lamivudine. Dig Dis Sci, 2002, 47:1782-1785.
7Brow KE, Tisdale J, Barrett AJ, et al. Hepatitis-associated aplastie anemia. N Engl J Med, 1997, 336: 1059-1064.
9Kaufman DW, Issaragfil S, Anderson T, et al. Use of household pesticids arid the risk of aplasfic anemia in Thailand. Int J Epidemiol, 1997,26: 643-650.
5Hamerschlak N, Maluf E, Pasquini R, et al. Incidence of aplastic anemia and agranulocytosis in Latin America-the LATIN study. Sao Paulo Med J,2005,123 : 101-104.
6McCahon E, Tang K, Rogers PC, et al. The impact of Asian descent on the incidence of acquired severe aplastic anaemia in children. Br J Haematol,2003 ,121:170-172.
7Saunthararajah Y, Nakamura R, Nam JM, et al. HLA-DR15 (DR2) is overrepresented in myelodysplastic syndrome and aplastic anemia and predicts a response to immunosuppression in myelodysplastic syndrome. Blood,2002,100 : 1570-1574.
8Maciejewski JP, Follmann D, Nakamura R, et al. Increased frequency of HLA-DR2 in patients with paroxysmal nocturnal hemoglobinuria and the PNH/aplastic anemia syndrome. Blood,2001, 98:3513-3519.
9Sugimori C, Yamazaki H. Roles of DRB1 * 1501 and DRB1 * 1502 in the pathogenesis of aplastic anemia. Exp Hematol,2007, 35 : 13-20.
10Kapustin SI, Popova TI, Lyshchov AA, et al. HLA-DR4-Ala74 beta is associated with risk and poor outcome of severe aplastic anemia. Ann Hematol,2001,80 : 66-71.
